Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.

Autor:	Coleman, Robert L.1 rcoleman@mdanderson.org, Oza, Amit M.2, Lorusso, Domenica3, Aghajanian, Carol4, Oaknin, Ana5, Dean, Andrew6, Colombo, Nicoletta7, Weberpals, Johanne I.8, Clamp, Andrew9, Scambia, Giovanni10, Leary, Alexandra11, Holloway, Robert W.12, Amenedo Gancedo, Margarita13, Fong, Peter C.14, Goh, Jeffrey C.15, O'Malley, David M.16, Armstrong, Deborah K.17, Garcia-Donas, Jesus18, Swisher, Elizabeth M.19, Floquet, Anne20
Zdroj:	Lancet. 10/28/2017, Vol. 390 Issue 10106, p1949-1961. 13p. 2 Diagrams, 3 Charts, 2 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu